Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression.
Silvia MigliariMaura ScarlatteiGiorgio BaldariLivia RuffiniPublished in: EJNMMI radiopharmacy and chemistry (2023)
[68Ga]68Ga-DOTA-ECL1i was successfully synthesized and it is, thus, available for multi-dose application in clinical settings.